Product Information
ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML is a generic product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $638.8046 per EA under NDC 00597057550. Its NADAC has been published 36 times since Dec 17, 2025.
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597057550
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Biologic (BLA)
FDA Application
BLA761058On Market Since
4/30/2024
Price Statistics
The NADAC for ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML has been published 36 times since Dec 17, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $638.8046 per EA |
|---|---|
| All-time high | $638.8046 (Aug 19, 2026) |
| All-time low | $636.0367 (Dec 17, 2025) |
| 52-week high | $638.8046 |
| 52-week low | $636.0367 |
| Median price | $636.3782 |
| Average price | $636.9315 |
| Largest weekly change | +0.1% (May 20, 2026) |
| Weeks tracked | 36 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML?
The current National Average Drug Acquisition Cost (NADAC) for ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $638.8046 per EA (NDC 00597057550), effective Aug 19, 2026.
How has the price of ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML changed over time?
Over the history we have for it, the NADAC for ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML has held within roughly two percent of its current level. It has been tracked across 36 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML?
Since Dec 17, 2025, the NADAC for ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML has ranged from a low of $636.0367 (Dec 17, 2025) to a high of $638.8046 (Aug 19, 2026), with a median of $636.3782 per EA.
Are there cheaper alternatives to ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML in a comparable dosage form, but none are currently priced below it.
Who manufactures ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML?
ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML (NDC 00597057550) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a generic product.